• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Abdominal Pain (1685); Diarrhea (1811); Fatigue (1849); Fever (1858); Headache (1880); Menstrual Irregularities (1959); Nausea (1970); Pain (1994); Abnormal Vaginal Discharge (2123); Vomiting (2144); Arthralgia (2355); Abdominal Cramps (2543); Weight Changes (2607)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of pelvic pain ("pelvic pain/ bilateral pelvic pain that was sharp and constant/ chronic pelvic pain/ chronic pain") in an adult female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On (b)(6) 2012, the patient had essure inserted.In (b)(6) 2012, the patient experienced abdominal pain lower ("abdominal cramping/ intermittent episodes of cramping/ abdominal cramps/ cramps/ right lower quadrant sensitivity and bilateral pain"), diarrhoea ("diarrhea"), pyrexia ("a fever of 101 degree f"), vomiting ("vomiting") and nausea ("nausea").On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), arthralgia ("joint pain"), weight increased ("weight gain"), fatigue ("fatigue"), amenorrhoea ("amenorrhea"), migraine ("migraines"), vaginal haemorrhage ("vaginal bleeding"), vaginal discharge ("brown vaginal discharge"), pain in extremity ("leg pain"), pain ("full body hurts"), abdominal pain ("sharp, stabbing abdominal pain /abdominal pain"), menstruation irregular ("irregular menses") and dysmenorrhoea ("dysmenorrhea").The patient was treated with total abdominal hysterectomy with removal of the essure devices on (b)(6) 2014.At the time of the report, the pelvic pain, arthralgia, weight increased, fatigue, amenorrhoea, migraine, abdominal pain lower, diarrhoea, pyrexia, vomiting, nausea, vaginal haemorrhage, vaginal discharge, pain in extremity, pain, menstruation irregular and dysmenorrhoea outcome was unknown and the abdominal pain had not resolved.The reporter considered abdominal pain, abdominal pain lower, amenorrhoea, arthralgia, diarrhoea, dysmenorrhoea, fatigue, menstruation irregular, migraine, nausea, pain, pain in extremity, pelvic pain, pyrexia, vaginal discharge, vaginal haemorrhage, vomiting and weight increased to be related to essure.The reporter commented: plaintiff underwent a pelvic ultrasound that showed the essure devices to be properly positioned, and was prescribed flagyl and naproxen.Diagnostic results (normal ranges are provided in parenthesis if available): hysterosalpingogram - on (b)(6) 2012: occlusion was viewed in both fallopian tubes ultrasound pelvis - on an unknown date: showed essure devices to be properly positioned ultrasound scan vagina - on (b)(6) 2014: revealed a right ovarian cyst according to pathology report, no fallopian tubes were submitted to the pathologist, just the ¿stubs.¿ a ¿spring like insertion¿ was visible in the stub of the left fallopian tube.The report further states: ¿dissection of the right fallopian tube also reveals the presence of a spring-like occlusive device.¿ the microscopic description noted: ¿sections of the parametrium and tubal stubs in the vicinity of the uterine cornu reveal focal mild chronic inflammation with associated scan foreign body giant cell inflammation.¿ incident.No lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981
MDR Report Key7055285
MDR Text Key92845138
Report Number2951250-2017-07029
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Other
Type of Report Initial
Report Date 11/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/27/2017
Initial Date FDA Received11/23/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-